Novel Serine Protease Dipeptidyl Peptidase IV Inhibitor: Alogliptin

E-ISSN： 1875-5607|12|13|1345-1358

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.12, Iss.13, 2012-11, pp. : 1345-1358

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preclinical development of dipeptidyl peptidase IV inhibitor alogliptin: a brief overview

By Parsa Kishore VL Pal Manojit

Expert Opinion on Drug Discovery, Vol. 6, Iss. 8, 2011-08 ,pp. : 855-869

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological profile of ASP8497, a novel, selective, and competitive dipeptidyl peptidase-IV inhibitor, in vitro and in vivo

By Someya Yuka

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 377, Iss. 3, 2008-05 ,pp. : 209-217

Springer Publishing Company

Access to resources Recommend Favorite

The dipeptidyl peptidase-4 inhibitor alogliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis

By Fujii Yuki Abe Masanori Higuchi Terumi Mizuno Mari Suzuki Hiroko Matsumoto Shiro Ito Midori Maruyama Noriaki Okada Kazuyoshi Soma Masayoshi

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 3, 2013-02 ,pp. : 259-267

Informa Healthcare

Access to resources Recommend Favorite

Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes

By Pratley Richard E

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 3, 2009-02 ,pp. : 503-512

Informa Healthcare

Access to resources Recommend Favorite

Linagliptin: A Novel Methylxanthin Based Approved Dipeptidyl Peptidase-4 Inhibitor

Current Drug Targets, Vol. 13, Iss. 7, 2012-06 ,pp. : 970-983

Bentham Science Publishers

Access to resources Recommend Favorite